Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort  Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Axel.

Slides:



Advertisements
Similar presentations
Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.
Advertisements

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,
The Epidemic of the 20th Century: Coronary Heart Disease
Clinical Significance of Troponin I Efflux and Troponin Autoantibodies in Patients With Dilated Cardiomyopathy  Kati H. Miettinen, MSc, Susann Eriksson,
Impact of Co-morbidity on the Risk of First-Time Myocardial Infarction, Stroke, or Death After Single-Photon Emission Computed Tomography Myocardial Perfusion.
The Extent of Myocardial Injury During Prolonged Targeted Temperature Management After Out-of-Hospital Cardiac Arrest  Anders Morten Grejs, MD, Jakob.
Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO 
Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?  Susanne Elisabeth Hosbond,
Classification of Myocardial Infarction: Frequency and Features of Type 2 Myocardial Infarction  Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Susanne.
Incidence, Frequency, and Clinical Characteristics of Type 3 Myocardial Infarction in Clinical Practice  Nikolaj Jangaard, MD, Laura Sarkisian, MD, Lotte.
Heather C. Brod, MA, Stanley Lemeshow, PhD, Philip F. Binkley, MD, MPH 
Amay Parikh, MD, MBA, MS, Kunal Gupta, MD, MBA, Alan C
Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study  Torben Bjerregaard Larsen, MD,
Long-term Trends in Short-term Outcomes in Acute Myocardial Infarction
Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study  Torben Bjerregaard Larsen, MD,
Alexander A. Leung, MD, MPH, Finlay A. McAlister, MD, MSc, Samuel R. G
Sleep Apnea and Risk of Deep Vein Thrombosis: A Non-randomized, Pair-matched Cohort Study  Kun-Ta Chou, MD, Chin-Chou Huang, MD, Yuh-Min Chen, MD, PhD,
Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction  Stein Ørn, MD, John G.F. Cleland, MD, Matti.
Predicting Survival in Oldest Old People
Matthew I. Worthley, MBBS, PhD, FRACP, Fiona M
Systematic Review of the Mediterranean Diet for Long-Term Weight Loss
Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,
Subclinical Thyroid Disease and Mortality in the Elderly: A Retrospective Cohort Study  Alon Grossman, MD, MHA, Avraham Weiss, MD, Nira Koren-Morag, PhD,
Prognostic Value of Low Blood Glucose at the Presentation of E
CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation  Walid Saliba, MD, MPH, Gad Rennert,
Wandering Acute Myocardial Infarction
Todd A. Lee, PharmD, PhD, Brian Bartle, MPH, Kevin B. Weiss, MD, MPH 
Incidence and Mortality Rates of Syncope in the United States
Prognostic Importance of Low Admission Serum Creatinine Concentration for Mortality in Hospitalized Patients  Charat Thongprayoon, MD, Wisit Cheungpasitporn,
Thomas E. MacMillan, MD, MSc, Terence Tang, MD, Rodrigo B
The Extent of Myocardial Injury During Prolonged Targeted Temperature Management After Out-of-Hospital Cardiac Arrest  Anders Morten Grejs, MD, Jakob.
Body Mass Index and Mortality in Acute Myocardial Infarction Patients
Epidemiology of Myelodysplastic Syndromes
Trend in Mortality after Stroke with Atrial Fibrillation
A Randomized, Double-Blind, Placebo-Controlled Trial of Nutritional Supplementation During Acute Illness  Salah Gariballa, MD, Sarah Forster, MSc, Stephen.
The Impact of Race on the Prognosis of Preclinical Diastolic Dysfunction: A Large Multiracial Urban Population Study  Jian Shan, MD, Lili Zhang, MD, MSc,
Laura Sarkisian, MD, Lotte Saaby, MD, PhD, Tina S
The Effect of a Statewide Smoking Ordinance on Acute Myocardial Infarction Rates  Paul Basel, BS, Becki Bucher Bartelson, PhD, Marie Claire Le Lait, MS,
The Epidemic of the 20th Century: Coronary Heart Disease
One-hour Rule-in and Rule-out of Acute Myocardial Infarction Using High-sensitivity Cardiac Troponin I  Maria Rubini Gimenez, MD, Raphael Twerenbold,
All-cause Mortality Associated with TNF-α Inhibitors in Rheumatoid Arthritis: A Meta- Analysis of Randomized Controlled Trials  Lucile Poiroux, MD, Yannick.
Carotid Sinus Massage in Patients with Suspected Acute Myocardial Infarction, Tachycardia, and Left Bundle Branch Block  Teddy Weiss, MD, Yair Elitzur,
Antibiotic Therapy and 48-Hour Mortality for Patients with Pneumonia
Robert Goulden, MBBS, MSc, MPhil, MA  The American Journal of Medicine 
A new lease on life for patients with Duchenne muscular dystrophy in Japan  Fumihiko Yasuma, MD, Masaaki Konagaya, MD, Motoko Sakai, MD, Satoshi Kuru,
Quality of Care for Myocardial Infarction at Academic and Nonacademic Hospitals  Loic Belle, MD, José Labarère, MD, Magali Fourny, MSc, Elodie Drouet,
Matthew W. Parker, MD, Murray A. Mittleman, MD, DrPH, Carol A
Incidence, Frequency, and Clinical Characteristics of Type 3 Myocardial Infarction in Clinical Practice  Nikolaj Jangaard, MD, Laura Sarkisian, MD, Lotte.
Classification of Myocardial Infarction: Frequency and Features of Type 2 Myocardial Infarction  Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Susanne.
Repeated Hemoglobin A1C Ordering in the VA Health System
Type 1 and 2 Myocardial Infarction and Myocardial Injury: Clinical Transition to High- Sensitivity Cardiac Troponin I  Yader Sandoval, MD, Stephen W. Smith,
Scope of Problem of Pulmonary Arterial Hypertension
The Reply The American Journal of Medicine
Yader Sandoval, MD, Stephen W. Smith, MD, Sara A
Clinical Outcomes After Treatment of Cocaine-Induced Chest Pain with Beta-Blockers: A Systematic Review and Meta-Analysis  Kevin Bryan Lo, MD, Hafeez.
Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort  Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Axel.
Shannon M. Dunlay, MD, MS, Quinn R. Pack, MD, Randal J
John-Michael Gamble, BScPharm, MSc, Dean T. Eurich, PhD, Thomas J
Reinfarction in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): Coronary Findings and Prognosis  Anna M. Nordenskjöld,
Heather C. Brod, MA, Stanley Lemeshow, PhD, Philip F. Binkley, MD, MPH 
A Post-cure Complication
Trends in Prolonged Hospitalizations in the United States from 2001 to 2012: A Longitudinal Cohort Study  Lauren Doctoroff, MD, Douglas J. Hsu, MD, Kenneth.
The Association Between Barium Examination and Subsequent Appendicitis: A Nationwide Population-Based Study  Hao-Ming Li, MD, Lee-Ren Yeh, MD, Ying-Kai.
Direct Observation of Residents: A Model for an Assessment System
Has mortality from acute renal failure decreased
Matthew W. Martinez, MD, Keith G. Rasmussen, MD, Paul S
Prevalence and Significance of Unrecognized Renal Dysfunction in Patients with Acute Coronary Syndrome  Zach Rozenbaum, MD, Avi Leader, MD, Yoram Neuman,
Preoperative Thienopyridine Use and Outcomes after Surgery: A Systematic Review  Anita G. Au, MD, Sumit R. Majumdar, MD MPH, Finlay A. McAlister, MD MSc 
Significance of Comorbid Psychological Stress and Depression on Outcomes After Cardiac Rehabilitation  Sergey Kachur, MD, Arthur R. Menezes, MD, Alban.
Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States  Ahmet Ergin, MD, PhD, MPH, Paul.
Presentation transcript:

Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort  Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Axel Cosmus Pyndt Diederichsen, MD, PhD, Susanne Hosbond, MD, Torben Bjerregaard Larsen, MD, PhD, Henrik Schmidt, MD, DMSc, Oke Gerke, MSc, PhD, Jesper Hallas, MD, DMSc, Kristian Thygesen, MD, DMSc, Hans Mickley, MD, DMSc  The American Journal of Medicine  Volume 127, Issue 4, Pages 295-302 (April 2014) DOI: 10.1016/j.amjmed.2013.12.020 Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 Flow diagram illustrating patient inclusion. cTnI = cardiac troponin I. The American Journal of Medicine 2014 127, 295-302DOI: (10.1016/j.amjmed.2013.12.020) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 2 Kaplan-Meier survival curves according to classification of myocardial infarction in type 1 and type 2. MI = myocardial infarction. The American Journal of Medicine 2014 127, 295-302DOI: (10.1016/j.amjmed.2013.12.020) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 3 Association between triggering conditions and mortality in patients with type 2 myocardial infarction. In 14 of 119 patients, more than 1 triggering condition was identified (2 in 12 patients and 3 in 2 patients). The American Journal of Medicine 2014 127, 295-302DOI: (10.1016/j.amjmed.2013.12.020) Copyright © 2014 Elsevier Inc. Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.